vs
Side-by-side financial comparison of CaliberCos Inc. (CWD) and Scilex Holding Co (SCLX). Click either name above to swap in a different company.
Scilex Holding Co is the larger business by last-quarter revenue ($4.8M vs $4.1M, roughly 1.2× CaliberCos Inc.). CaliberCos Inc. runs the higher net margin — -188.3% vs -961.9%, a 773.6% gap on every dollar of revenue. On growth, CaliberCos Inc. posted the faster year-over-year revenue change (-52.5% vs -67.8%). Over the past eight quarters, Scilex Holding Co's revenue compounded faster (-33.6% CAGR vs -57.6%).
CaliberCos Inc. is a U.S.-headquartered alternative asset management firm focused primarily on real estate investments. It offers a diverse suite of investment vehicles covering commercial, residential, and industrial real estate assets, serving institutional investors, high-net-worth individuals, and retail clients across North America. It also delivers asset management, property operation, and value-add real estate development services to support consistent long-term returns for investors.
Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.
CWD vs SCLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.1M | $4.8M |
| Net Profit | $-7.7M | $-46.1M |
| Gross Margin | — | 45.5% |
| Operating Margin | -196.6% | -2317.8% |
| Net Margin | -188.3% | -961.9% |
| Revenue YoY | -52.5% | -67.8% |
| Net Profit YoY | 32.2% | -613.7% |
| EPS (diluted) | $1.95 | $-4.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.1M | $4.8M | ||
| Q3 25 | $3.6M | $10.6M | ||
| Q2 25 | $5.1M | $9.9M | ||
| Q1 25 | $7.3M | $5.0M | ||
| Q4 24 | $8.7M | $14.9M | ||
| Q3 24 | $11.3M | $14.4M | ||
| Q2 24 | $8.2M | $16.4M | ||
| Q1 24 | $23.0M | $10.9M |
| Q4 25 | $-7.7M | $-46.1M | ||
| Q3 25 | $-4.4M | $-257.8M | ||
| Q2 25 | $-5.3M | $-44.0M | ||
| Q1 25 | $-4.4M | $-26.1M | ||
| Q4 24 | $-11.4M | $-6.5M | ||
| Q3 24 | $146.0K | $-4.4M | ||
| Q2 24 | $-4.7M | $-37.6M | ||
| Q1 24 | $-3.8M | $-24.4M |
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 68.5% | ||
| Q2 25 | — | 66.9% | ||
| Q1 25 | — | 72.3% | ||
| Q4 24 | — | 68.5% | ||
| Q3 24 | — | 73.9% | ||
| Q2 24 | — | 73.2% | ||
| Q1 24 | — | 64.7% |
| Q4 25 | -196.6% | -2317.8% | ||
| Q3 25 | -129.6% | -1766.2% | ||
| Q2 25 | -112.4% | -207.2% | ||
| Q1 25 | -62.7% | -557.5% | ||
| Q4 24 | -236.8% | -190.5% | ||
| Q3 24 | 0.0% | -138.0% | ||
| Q2 24 | -65.0% | -95.4% | ||
| Q1 24 | -22.9% | -179.0% |
| Q4 25 | -188.3% | -961.9% | ||
| Q3 25 | -120.2% | -2441.5% | ||
| Q2 25 | -104.5% | -445.1% | ||
| Q1 25 | -60.7% | -521.2% | ||
| Q4 24 | -247.6% | -43.4% | ||
| Q3 24 | 1.3% | -30.4% | ||
| Q2 24 | -57.8% | -229.6% | ||
| Q1 24 | -16.6% | -224.0% |
| Q4 25 | $1.95 | $-4.63 | ||
| Q3 25 | $-1.65 | $-22.17 | ||
| Q2 25 | $-4.15 | $-7.42 | ||
| Q1 25 | $-3.85 | $-2.26 | ||
| Q4 24 | $-10.15 | $8.53 | ||
| Q3 24 | $0.12 | $-0.58 | ||
| Q2 24 | $-4.34 | $-7.67 | ||
| Q1 24 | $-3.53 | $-8.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.9M | $5.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3M | $-207.8M |
| Total Assets | $135.4M | $365.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9M | $5.0M | ||
| Q3 25 | $10.9M | $878.0K | ||
| Q2 25 | $683.0K | $4.1M | ||
| Q1 25 | $1.6M | $5.8M | ||
| Q4 24 | $2.3M | $3.3M | ||
| Q3 24 | $1.6M | $77.0K | ||
| Q2 24 | $1.8M | $6.9M | ||
| Q1 24 | $2.1M | $1.8M |
| Q4 25 | $1.3M | $-207.8M | ||
| Q3 25 | $4.2M | $-176.9M | ||
| Q2 25 | $-19.9M | $-249.0M | ||
| Q1 25 | $-15.8M | $-211.5M | ||
| Q4 24 | $-12.6M | $-192.6M | ||
| Q3 24 | $-3.8M | $-211.3M | ||
| Q2 24 | $-4.7M | $-214.7M | ||
| Q1 24 | $-745.0K | $-189.8M |
| Q4 25 | $135.4M | $365.0M | ||
| Q3 25 | $82.6M | $275.9M | ||
| Q2 25 | $59.3M | $83.8M | ||
| Q1 25 | $103.6M | $79.0M | ||
| Q4 24 | $105.5M | $93.0M | ||
| Q3 24 | $158.6M | $100.4M | ||
| Q2 24 | $195.2M | $104.5M | ||
| Q1 24 | $201.5M | $91.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-12.1M | $-17.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-12.1M | $-17.5M | ||
| Q3 25 | $-4.6M | $8.2M | ||
| Q2 25 | $-1.2M | $7.0M | ||
| Q1 25 | $-1.7M | $6.0M | ||
| Q4 24 | $555.0K | $2.5M | ||
| Q3 24 | $-74.0K | $5.1M | ||
| Q2 24 | $1.4M | $2.3M | ||
| Q1 24 | $-1.5M | $9.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.51× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
